drugset / Trial / NCT05645887
Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this phase 2, multicenter, randomized, controlled study is to evaluate the effect of albumin treatment on B cell and other immune cell gene exptression in adults with septic shock.
Timeline
- Start
- 2024-02
- Primary completion
- 2024-05-23
- Completion
- 2024-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | 20 % | Intravenous |
| Subject | Albumin | Protein / enzyme biologic | 300 ml | Intravenous |
| Subject | Albumin | Protein / enzyme biologic | 60 g | Intravenous |